JVAQX
Price
$40.67
Change
+$0.36 (+0.89%)
Updated
Sep 4 closing price
Net Assets
9.17B
RMFCX
Price
$60.45
Change
+$0.07 (+0.12%)
Updated
Sep 5 closing price
Net Assets
109.34B
Interact to see
Advertisement

JVAQX vs RMFCX

Header iconJVAQX vs RMFCX Comparison
Open Charts JVAQX vs RMFCXBanner chart's image
JPMorgan Value Advantage R4
Price$40.67
Change+$0.36 (+0.89%)
VolumeN/A
Net Assets9.17B
American Funds American Mutual R3
Price$60.45
Change+$0.07 (+0.12%)
VolumeN/A
Net Assets109.34B
JVAQX vs RMFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVAQX vs. RMFCX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVAQX is a Buy and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 109B vs. JVAQX (9.17B). JVAQX pays higher dividends than RMFCX: JVAQX (1.42) vs RMFCX (1.24). JVAQX was incepted earlier than RMFCX: JVAQX (9 years) vs RMFCX (23 years). JVAQX (1.03) is less costly to investors than RMFCX (0.91). RMFCX is a more actively managed with annual turnover of: 31.00 vs. JVAQX (17.00). JVAQX has a lower initial minimum investment than RMFCX: JVAQX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 7.71 vs. JVAQX (0.99). RMFCX return over 5 years is better than : 56.41 vs. JVAQX (35.77).
JVAQXRMFCXJVAQX / RMFCX
Total Expense Ratio0.750.9182%
Annual Report Gross Expense Ratio1.030.91113%
Fund Existence9 years23 years-
Gain YTD7.33711.42164%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets9.17B109B8%
Annual Yield % from dividends1.421.24115%
Returns for 1 year0.997.7113%
Returns for 3 years13.1232.1641%
Returns for 5 years35.7756.4163%
Returns for 10 yearsN/A91.12-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTAI3.790.22
+6.16%
BioXcel Therapeutics Inc
CAN0.710.02
+3.26%
Canaan
TECH54.411.49
+2.82%
Bio-Techne Corp
KMT21.950.12
+0.55%
Kennametal
HSPOU12.21N/A
N/A
Horizon Space Acquisition I Corp